Retinal ganglion cell loss in kinesin-1 cargo Alcadein α deficient mice.
Yuki NakanoKazuyuki HirookaYoichi ChibaMasaki UenoDaiki OjimaMd Razib HossainHiroo TakahashiTohru YamamotoYoshiaki KiuchiPublished in: Cell death & disease (2020)
Maintenance of retinal ganglion cells (RGCs) activity is relied on axonal transport conveying materials required for their survival such as neurotrophic factors. Kinesin-1 undergoes anterograde transport in axons, and Alcadein α (Alcα; also called calsyntenin-1) is a major cargo adaptor protein that can drive kinesin-1 to transport vesicles containing Alcα. The long-term effects of Alcα-deficiency on retinal morphology and survival of RGCs during postnatal development were examined in Alcα knockout mice. At 1.5, 3, 6, and 15 months postnatal, the number of retrogradely labeled RGCs was determined in flat-mounted retinas of Alcα-deficient and wild-type mice. Retinal damage was assessed histologically by determining the retinal thickness. Intraocular pressure (IOP) was measured with a Tonolab tonometer. At 1.5 months postnatal, the number of retrogradely labeled RGCs was not different between wild-type and Alcα-deficient mice. However, at 3, 6, and 15 months postnatal, the number of RGCs was significantly lower in Alcα deficient mice than those of wild-type mice (143 ± 41.1 cells/mm2 vs. 208 ± 28.4 cells/mm2, respectively, at 3 months; P < 0.01). No differences were seen in retinal thickness or IOP between the two types of mice at any postnatal age. Alcα-deficient mice showed spontaneous loss of RGCs but no elevation in IOP. These mice mimic normal-tension glaucoma and will be useful for investigating the mechanism of neurodegeneration in this disorder and for developing treatments for RGC loss that does not involve changes in IOP.
Keyphrases
- wild type
- optical coherence tomography
- induced apoptosis
- preterm infants
- diabetic retinopathy
- optic nerve
- cell cycle arrest
- oxidative stress
- spinal cord injury
- endoplasmic reticulum stress
- high fat diet induced
- type diabetes
- signaling pathway
- computed tomography
- cell therapy
- adipose tissue
- small molecule
- cell death
- skeletal muscle
- replacement therapy